Emyria Limited (ASX:EMD)
Australia · Delayed Price · Currency is AUD 0.0470
+0.0010 (2.17%)
Sep 30, 2026, 9:59 AM AEST
Emyria Revenue
In the fiscal year ending June 30, 2026, Emyria had annual revenue of 4.05M AUD with 190.62% growth. Emyria had revenue of 2.50M in the half year ending June 30, 2026, with 124.50% growth.
Revenue
4.05M
Revenue Growth
+190.62%
P/S Ratio
9.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.05M | 2.66M | 190.62% |
| Jun 30, 2025 | 1.39M | -807.97K | -36.68% |
| Jun 30, 2024 | 2.20M | 610.25K | 38.32% |
| Jun 30, 2023 | 1.59M | -229.93K | -12.62% |
| Jun 30, 2022 | 1.82M | -153.51K | -7.77% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Doctor Care Anywhere Group | 75.18M |
| Beamtree Holdings | 29.19M |
| Mach7 Technologies | 27.95M |
| Resonance Health | 15.75M |
| Pharmx Technologies | 7.62M |
| Vitasora Health | 4.84M |
| PainChek | 3.74M |
| Intelicare Holdings | 2.04M |
Emyria News
- 21 days ago - Emyria Earnings Call Transcript: H2 2026 - Transcripts
- 21 days ago - Emyria Annual report: H2 2026 - Filings
- 21 days ago - Emyria Slides: H2 2026 - Filings
- 2 months ago - Emyria Earnings Call Transcript: Q4 2026 - Transcripts
- 2 months ago - Emyria Earnings release: Q4 2026 - Filings
- 5 months ago - Emyria Earnings Call Transcript: Q3 2026 - Transcripts
- 5 months ago - Emyria Slides: Q3 2026 - Filings
- 5 months ago - Emyria Earnings release: Q3 2026 - Filings